Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.

This study explores how the horse’s body processes propafenone, a medication used to treat irregular heartbeats, by comparing two different analytical models. The research found that the drug is heavily distributed and cleared rapidly in horses.

Research Objective

• The main goal of this study was to understand how propafenone, a cardiac drug, behaves in the body of a horse after being administered intravenously. This was evaluated through the use of two differing analytical models: compartmental and noncompartmental models.

Methodology

• The scientists administered propafenone through an intravenous route and then monitored the drug’s kinetics, which includes absorption, distribution, metabolism, and excretion, over a specified period of time.
• Both compartmental and noncompartmental models were used to analyze the kinetic data, allowing for a comparative assessment. Compartmental models assume the body to be divided into compartments and the drug to move between them, while noncompartmental models do not make such assumptions and provide a more ‘real-world’ perspective.

Findings

• The research established that propafenone has a large volume of distribution (Vdss = 1021 +/- 211 L) and a high clearance rate (CI = 7019 +/- 1746 mL/min) in horses. This means the drug is distributed extensively throughout the body and is also eliminated quickly.
• Most plasma concentrations of the drug were found to be very low, generally under 1 microgram/mL. These concentrations decreased to negligible levels after about 30 minutes, suggesting that they are not sufficient for effective arrhythmia treatment.

Conclusions

• There were no significant differences between the pharmacokinetic parameters (distribution and clearance rates) obtained using either compartmental or noncompartmental models. This suggests that both models are equally efficient and accurate for analyzing propafenone kinetics in horses.